These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 22209080
1. Elevated urinary sVCAM-1, IL6, sIL6R and TNFR1 concentrations indicate acute kidney transplant rejection in the first 2 weeks after transplantation. Reinhold SW, Straub RH, Krüger B, Kaess B, Bergler T, Weingart C, Banas MC, Krämer BK, Banas B. Cytokine; 2012 Mar; 57(3):379-88. PubMed ID: 22209080 [Abstract] [Full Text] [Related]
2. Serial measurements of interleukin-6, interleukin-8, tumor necrosis factor-alpha, and soluble vascular cell adhesion molecule-1 in the peripheral blood plasma of human cardiac allograft recipients. George JF, Kirklin JK, Naftel DC, Bourge RC, White-Williams C, McGiffin DC, Savunen T, Everson MP. J Heart Lung Transplant; 1997 Oct; 16(10):1046-53. PubMed ID: 9361247 [Abstract] [Full Text] [Related]
3. Association between graft function and serum TNF-α, TNFR1 and TNFR2 levels in patients with kidney transplantation. Budak D, Yilmaz VT, Akbas H, Suleymanlar G, Yucel G. Ren Fail; 2015 Jun; 37(5):871-6. PubMed ID: 25707514 [Abstract] [Full Text] [Related]
4. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection. Ramsperger-Gleixner M, Spriewald BM, Tandler R, Kondruweit M, Amann K, Weyand M, Ensminger SM. Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046 [Abstract] [Full Text] [Related]
5. Serum soluble interleukin 2 receptor (sIL-2R) as a marker of acute rejection in renal transplant children. García-Roca P, Vargas YA, Fuentes Y, Hernández AM, Ortiz L, Valverde S, Velásquez-Jones L, Romero-Navarro B, Ramón-Garcia G, Medeiros M. Pediatr Transplant; 2012 May; 16(3):274-9. PubMed ID: 22309031 [Abstract] [Full Text] [Related]
6. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Prodjosudjadi W, Daha MR, Gerritsma JS, Florijn KW, Barendregt JN, Bruijn JA, van der Woude FJ, van Es LA. Nephrol Dial Transplant; 1996 Jun; 11(6):1096-103. PubMed ID: 8671975 [Abstract] [Full Text] [Related]
7. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection. Kamali K, Abbasi MA, Farokhi B, Abbasi A, Fallah P, Seifee MH, Ghadimi N, Rezaie AR. Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374 [Abstract] [Full Text] [Related]
8. Pre-transplant elevations of interleukin-12 and interleukin-10 are associated with acute rejection after renal transplantation. Fitzgerald JT, Johnson JR, Perez RV. Clin Transplant; 2004 Aug; 18(4):434-9. PubMed ID: 15233822 [Abstract] [Full Text] [Related]
9. Association of high pretransplant sIL-6R plasma levels with acute tubular necrosis in kidney graft recipients. Sadeghi M, Daniel V, Naujokat C, Mehrabi A, Opelz G. Transplantation; 2006 Jun 27; 81(12):1716-24. PubMed ID: 16794539 [Abstract] [Full Text] [Related]
10. Soluble CD30 in renal transplant recipients: is it a good biomarker to predict rejection? Azarpira N, Aghdaie MH, Malekpour Z. Saudi J Kidney Dis Transpl; 2010 Jan 27; 21(1):31-6. PubMed ID: 20061689 [Abstract] [Full Text] [Related]
11. Value of serum soluble tumour necrosis factor concentrations in the diagnosis and prognosis of renal graft rejection. Keil M, Pec MK, Schenn G, Grünberger T, Kramer G, Függer R, Steininger R, Mühlbacher F, Balcke P, Stockenhuber F. Nephrol Dial Transplant; 1994 Jan 27; 9(7):815-9. PubMed ID: 7970125 [Abstract] [Full Text] [Related]
12. Interleukin-10 production genotype protects against acute persistent rejection after lung transplantation. Zheng HX, Burckart GJ, McCurry K, Webber S, Ristich J, Iacono A, Dauber J, McDade K, Grgurich W, Zaldonis D, Pillage G, Griffith BP, Zeevi A. J Heart Lung Transplant; 2004 May 27; 23(5):541-6. PubMed ID: 15135368 [Abstract] [Full Text] [Related]
13. Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha -308 single nucleotide polymorphisms: a preliminary study. Gendzekhadze K, Rivas-Vetencourt P, Montano RF. Transpl Immunol; 2006 Nov 27; 16(3-4):194-9. PubMed ID: 17138053 [Abstract] [Full Text] [Related]
14. Decreasing plasma soluble IL-1 receptor antagonist and increasing monocyte activation early post-transplant may be involved in pathogenesis of delayed graft function in renal transplant recipients. Sadeghi M, Daniel V, Naujokat C, Schmidt J, Mehrabi A, Zeier M, Opelz G. Clin Transplant; 2010 Nov 27; 24(3):415-23. PubMed ID: 19925477 [Abstract] [Full Text] [Related]
15. Changes of progesterone-induced blocking factor in patients after kidney transplantation. Fekecs T, Kalmár-Nagy K, Szakály P, Németh K, Moezzi M, Zapf I, Horváth OP, Bartho-Szekeres J, Ferencz A. Transplant Proc; 2011 Dec 27; 43(10):3694-6. PubMed ID: 22172828 [Abstract] [Full Text] [Related]
16. Temporal changes of cytokines and nitric oxide products in urine from renal transplant patients. Smith SD, Wheeler MA, Lorber MI, Weiss RM. Kidney Int; 2000 Aug 27; 58(2):829-37. PubMed ID: 10916108 [Abstract] [Full Text] [Related]
17. [Cytokine gene polymorphism in sensitized kidney transplant recipients and its association with acute rejection episodes]. Gu XW, Zhao M, Li LY, Li M, Qian J. Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov 27; 23(11):1211-3. PubMed ID: 14625191 [Abstract] [Full Text] [Related]
18. Urine of patients with acute kidney transplant rejection show high normetanephrine and decreased 2-hydroxyestrogens concentrations. Reinhold SW, Straub RH, Bergler T, Hoffmann U, Krüger B, Banas MC, Kammerl MC, Kollins D, Krämer BK, Banas B. Transplant Proc; 2013 May 27; 45(4):1503-7. PubMed ID: 23726606 [Abstract] [Full Text] [Related]
19. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Slavcev A, Lácha J, Honsová E, Sajdlová H, Lodererová A, Vitko S, Skibová J, Striz I. Transpl Immunol; 2005 Jun 27; 14(2):117-21. PubMed ID: 15935302 [Abstract] [Full Text] [Related]
20. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Visser W, Beckmann I, Knook MA, Wallenburg HC. Acta Obstet Gynecol Scand; 2002 Aug 27; 81(8):713-9. PubMed ID: 12174154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]